Study to Evaluate the PK and Safety of Oral Decitabine and Cedazuridine in Cancer Patients with Hepatic Impairment
ASTX727-18
Phase 1 other active
Quick answer
Study to Evaluate the PK and Safety of Oral Decitabine and Cedazuridine in Cancer Patients with Hepatic Impairment for Solid tumor, Acute myeloid lymphoma (AML), Myelodysplastic syndrome (MDS) is a Phase 1 program (other) at Taiho Pharma Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Taiho Pharma Netherlands B.V.
- Indication
- Solid tumor, Acute myeloid lymphoma (AML), Myelodysplastic syndrome (MDS)
- Phase
- Phase 1
- Modality
- other
- Status
- active